189
Views
1
CrossRef citations to date
0
Altmetric
Brief Report

Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men

, , , , , , , , , , , , , & show all
Pages 56-61 | Received 18 May 2018, Accepted 04 Jul 2018, Published online: 14 Oct 2018

References

  • Redd AD, Quinn TC, Tobian AA. Frequency and implications of HIV superinfection. Lancet Infect Dis. 2013;13:622–628.
  • Redd AD, Mullis CE, Serwadda D, et al. The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J Infect Dis. 2012;206:267–274.
  • Ronen K, McCoy CO, Matsen FA, et al. HIV-1 superinfection occurs less frequently than initial infection in a cohort of high-risk Kenyan women. PLoS Pathog. 2013;9:e1003593.
  • Wagner GA, Pacold ME, Kosakovsky Pond SL, et al. Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States. J Infect Dis. 2014;209:1032–1038.
  • Ronen K, Dingens AS, Graham SM, et al. Comprehensive characterization of humoral correlates of Human Immunodeficiency Virus 1 superinfection acquisition in high-risk Kenyan women. EBioMedicine. 2017;18:216–224.
  • Smith DM, Strain MC, Frost SD, et al. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006;355:1–5.
  • Cortez V, Odem-Davis K, McClelland RS, et al. HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response. PLoS Pathog. 2012;8:e1002611.
  • Doria-Rose NA, Schramm CA, Gorman J, et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature. 2014;509:55–62.
  • Obel N, Engsig FN, Rasmussen LD, et al. Cohort profile: the Danish HIV cohort study. Int J Epidemiol. 2009;38:1202–1206.
  • Redd AD, Collinson-Streng A, Martens C, et al. Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol. 2011;49:2859–2867.
  • Lehman DA, Wamalwa DC, McCoy CO, et al. Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment. J Acquir Immune Defic Syndr. 2012;60:225–233.
  • Doria-Rose NA, Altae-Tran HR, Roark RS, et al. Mapping polyclonal HIV-1 antibody responses via next-generation neutralization fingerprinting. PLoS Pathog. 2017;13:e1006148.
  • Salado-Rasmussen K, Katzenstein TL, Gerstoft J, et al. Risk of HIV or second syphilis infection in Danish men with newly acquired syphilis in the period 2000–2010. Sex Transm Infect. 2013;89:372–376.
  • Wagner GA, Landais E, Caballero G, et al. Intrasubtype B HIV-1 superinfection correlates with delayed neutralizing antibody response. J Virol. 2017;91:e00475–17.
  • Connor RI, Montefiori DC, Binley JM, et al. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J Virol. 1998;72:7501–7509.
  • Cornelissen M, Euler Z, van den Kerkhof TL, et al. The neutralizing antibody response in an individual with triple HIV-1 infection remains directed at the first infecting subtype. AIDS Res Hum Retroviruses. 2016;32:1135–1142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.